Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid

Kidd, P. M. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern. Med. Rev. 12, 207–227 (2007)

Horrocks, L. A. & Yeo, Y. K. Health benefits of docosahexaenoic acid (DHA). Pharmacol. Res. 40, 211–225 (1999)

Mozaffarian, D. & Wu, J. H. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J. Am. Coll. Cardiol. 58, 2047–2067 (2011)

Connor, W. E. Importance of n-3 fatty acids in health and disease. Am. J. Clin. Nutr. 71, 171S–175S (2000)

Breckenridge, W. C., Gombos, G. & Morgan, I. G. The lipid composition of adult rat brain synaptosomal plasma membranes. Biochim. Biophys. Acta 266, 695–707 (1972)

Innis, S. M. Dietary (n-3) fatty acids and brain development. J. Nutr. 137, 855–859 (2007)

Salem, N., Jr, Litman, B., Kim, H. Y. & Gawrisch, K. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 36, 945–959 (2001)

Armulik, A. et al. Pericytes regulate the blood–brain barrier. Nature 468, 557–561 (2010)

Bell, R. D. et al. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68, 409–427 (2010)

Berger, J. H., Charron, M. J. & Silver, D. L. Major facilitator superfamily domain-containing protein 2a (MFSD2A) has roles in body growth, motor function, and lipid metabolism. PLoS ONE 7, e50629 (2012)

Lafourcade, M. et al. Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nature Neurosci. 14, 345–350 (2011)

Carrié, I., Clement, M., de Javel, D., Frances, H. & Bourre, J. M. Phospholipid supplementation reverses behavioral and biochemical alterations induced by n-3 polyunsaturated fatty acid deficiency in mice. J. Lipid Res. 41, 473–480 (2000)

Kim, H. Y. Novel metabolism of docosahexaenoic acid in neural cells. J. Biol. Chem. 282, 18661–18665 (2007)

Simopoulos, A. P. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp. Biol. Med. (Maywood) 233, 674–688 (2008)

Croset, M., Brossard, N., Polette, A. & Lagarde, M. Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem. J. 345, 61–67 (2000)

Granell, M., Leon, X., Leblanc, G., Padros, E. & Lorenz-Fonfria, V. A. Structural insights into the activation mechanism of melibiose permease by sodium binding. Proc. Natl Acad. Sci. USA 107, 22078–22083 (2010)

Paroder-Belenitsky, M. et al. Mechanism of anion selectivity and stoichiometry of the Na+/I- symporter (NIS). Proc. Natl Acad. Sci. USA 108, 17933–17938 (2011)

Shui, G. et al. Comparative plasma lipidome between human and cynomolgus monkey: are plasma polar lipids good biomarkers for diabetic monkeys? PLoS ONE 6, e19731 (2011)

Wong, P. et al. Pregnenolone rescues schizophrenia-like behavior in dopamine transporter knockout mice. PLoS ONE 7, e51455 (2012)